ReVacc Scientific provides reliable virology and immunology products and services to support scientific discovery, clinical diagnostics, and disease therapeutics.
Vicbio Biotechnology Co., Ltd. provides the full range of ReVacc Scientific products.
⇨ Inquire or Order immediately ⇦
Compared with traditional plaque assays, pseudoviruses carrying reporter genes (such as luciferase) offer an efficient solution for high-throughput sample screening. Based on multiple technology platforms, ReVacc Scientific produces pseudoviruses targeting coronaviruses, filoviruses, and highly pathogenic avian influenza viruses.
The company focuses on producing proteins containing key neutralizing epitopes, which are widely used in three major fields: vaccines, diagnostics, and therapeutics. Key advantages include:
• Use of eukaryotic expression systems (mammalian or insect cells) to ensure proper post-translational modifications.
• Recombinant proteins correctly assemble into their native oligomeric states (such as dimers or trimers).
Most antibodies exhibit neutralizing activity and are capable of blocking pathogen infection of host cells.
Designed for the detection of IgG or antigen levels in samples from humans, mice, or veterinary animals, with simple and convenient operation.
• One-step efficient DNA assembly
• High-efficiency transformation within one minute
ReVacc Scientific also offers a range of specialized services:
1) Neutralizing Antibody Titer Evaluation:Assessment of neutralizing activity in samples under compliant biosafety conditions.
2) Custom Protein Production:Production of customized proteins carrying specific mutations according to research needs.
3) Custom Pseudovirus Construction:Generation of pseudotyped viruses incorporating specific mutations upon request.
4) Diagnostic Kit Custom Development:Development of customized diagnostic kits based on client requirements.
5) Custom Antibody Discovery:The company has developed Multi-color Epitope-Specific Single-Cell Sorting (MESCS®) technology combined with recombinant monoclonal antibody techniques to discover valuable antibodies from samples across different species.
6) Antibody Engineering:Including antibody humanization, antibody labeling, antibody nucleotide sequence determination, antibody isotype switching, antibody format conversion, and species conversion.
7) Flow Cytometric Cell Sorting Service:Used to isolate cell populations with specific light-scattering and fluorescence characteristics.
| Product Name | Catalog | Size |
| VSV-Pseudovirus_SARS-CoV-2 WT (Wuhan Strain) Spike with luciferase reporter | P14N41 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 D614G (Spike D614G mutant) Spike with luciferase reporter | M32H50 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 B.1.1.7 (Alpha strain) Spike with luciferase reporter | L1X97 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 B.1.351 (Beta strain) Spike with luciferase reporter | G99O57 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 B.1.617.2 (Delta strain) Spike with luciferase reporter | D33Z75 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 B.1.1.529 (Omicron Strain) Spike with luciferase reporter | N64K21 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter | P40C22 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2.12.1 Spike with luciferase reporter | T44Q32 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.4/5 Spike with luciferase reporter | P63R98 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2.75 Spike with luciferase reporter | E43R80 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BF.7 Spike with luciferase reporter | F36Q75 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BQ.1.1 Spike with luciferase reporter | C50J18 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain XBB.1.5 Spike with luciferase reporter | T35V28 | |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain CH.1.1 Spike with luciferase reporter | S88C28 | |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain XBB.1.16 Spike with luciferase reporter | K10C77 | |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2.86 Spike with luciferase reporter | W19M63 | |
| VSV-Pseudovirus_SARS-CoV-2 Omicron Strain JN.1 Spike with luciferase reporter | Q73S60 | |
| Lenti-Pseudovirus_SARS-CoV-2 (Wuhan Strain) Spike with luciferase reporter | O21F29 | 1.1ml; 5.5ml |
| VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter | T53L53 | 200 μl; 1000 μl |
| VSV-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter | V44X39 | 200 μl; 1000 μl |
| Lenti-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter | U85H22 | 1.1ml; 5.5ml |
| VSV-Pseudovirus_ Marburg Angola strain GP with Luciferase Reporter | V51D96 | 200 μl; 1000 μl |
| VSV-Pseudovirus_ Marburg RAVN strain GP with Luciferase Reporter | N31O81 | 200 μl; 1000 μl |
| VSV-Pseudovirus_ Marburg Musoke strain GP with Luciferase Reporter | U75A99 | 200 μl; 1000 μl |
| VSV-Pseudovirus_ Ebola Zaire strain GP with Luciferase Reporter | S99W4 | 200 μl; 1000 μl |
| VSV-Pseudovirus_ Ebola Sudan strain GP with Luciferase Reporter | U95M81 | 200 μl; 1000 μl |
| VSV-Pseudovirus_ Ebola Bombali strain GP with Luciferase Reporter | T42Y99 | |
| Zika Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter | X40H97 | 200 μl; 1000 μl |
| Dengue Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (Type 1) | N91Y8 | 200 μl; 1000 μl |
| Dengue Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (Type 2) | X57D33 | 200 μl; 1000 μl |
| West Nile virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter (NY99 Strain) | A46U23 | 200 μl; 1000 μl |
| VSV-Pseudovirus HCV E1E2 with Luciferase Reporter (H77 strain) | P2R77 | 200 μl; 1000 μl |
| VSV-Pseudovirus Lassa Virus Glycoprotein Complex with Luciferase Reporter (Josiah Strain) | M85H4 | 200 μl; 1000 μl |
| Pseudovirus_HMPV Fusion with Luciferase Reporter (NL/1/00/A1 strain) | W95K98 | 200 μl; 1000 μl |
| Pseudovirus_HMPV Fusion with Luciferase Reporter (NL/1/99 B1 strain) | S20B95 | |
| Pseudovirus_RSV Fusion with Luciferase Reporter (A2 strain) | P11A48 | 200 μl; 1000 μl |
| Pseudovirus_RSV Fusion with Luciferase Reporter (VR26 strain) | P53F53 | 200 μl; 1000 μl |
| Pseudovirus Influenza A HPAI H5N1 virus HaNaM with Luciferase Reporter (clade 2.3.4.4b, 2022 strain) | S45R27 | 200 μl; 1000 μl |
| AAV-CMV-GFP (Serotype 1, 2, 5, 6, 7, 8, 9, DJ, U6, retro) | X97G10 | |
| Avian Influenza (A/VFAR-140/2022, H5N1) Recombinant HA Trimer Protein | N43D71 | 100 μg；500 μg |
| Dengue virus 1 E protein | R22F8 | 100 μg；500 μg |
| Dengue virus 2 E protein | W80T78 | 100 μg；500 μg |
| Dengue virus 2 PrM_E protein | V82T61 | 100 μg；500 μg |
| Ebola Sudan GP protein | B78A28 | 100 μg；500 μg |
| Ebola Zaire Makona GP protein | P54P89 | 100 μg；500 μg |
| Herpes simplex virus (HSV) gD protein (Type 1) | L61Q82 | 100 μg；500 μg |
| Herpes simplex virus (HSV) gD protein (Type 2) | T73G30 | 100 μg；500 μg |
| HIV-1 Trimeric GP140 protein-clade A, BG505 strain | U90R79 | 100 μg；500 μg |
| HIV-1 Trimeric GP140 protein-clade B, YU2 strain | W44H24 | 100 μg；500 μg |
| HIV-1 Trimeric GP140 protein-clade B, JRFL strain | G87X55 | 100 μg；500 μg |
| HIV-1 Trimeric GP140 protein- clade C, 16055 strain | E7P43 | 100 μg；500 μg |
| Marburg RAVN GP protein | I27A51 | 100 μg；500 μg |
| MERS-CoV Trimeric Spike protein | U97O74 | 100 μg；500 μg |
| Monkeypox Virus Trimeric A29 protein | Y58C40 | 100 μg；500 μg |
| Monkeypox Virus Dimeric A35R protein | S95L46 | 100 μg；500 μg |
| Monkeypox Virus B6R protein | F64X96 | 100 μg；500 μg |
| Nipah Virus (NiV) Glycoprotein | Z23E33 | 100 μg；500 μg |
| SARS-CoV Trimeric Spike protein (2003 strain) | Z18G29 | 100 μg；500 μg |
| SARS-CoV (2003 Strain) Spike protein Receptor Binding Domain (RBD) | V96K50 | 100 μg；500 μg |
| SARS-CoV-2 nucleocapsid (N) protein – Full length | W72G56 | 100 μg；500 μg |
| SARS-CoV-2 nucleocapsid (N) protein – C-terminal domain | M47G62 | 100 μg；500 μg |
| SARS-CoV-2 Trimeric Spike protein WT (Wuhan Strain) | C40N10 | 100 μg；500 μg |
| SARS-CoV-2 Trimeric Spike protein D614G (D614 mutant) | J23V36 | 100 μg；500 μg |
| SARS-CoV-2 Trimeric Spike protein B.1.351 (Beta variant) | R12T26 | 100 μg；500 μg |
| SARS-CoV-2 Trimeric Spike protein B.1.617.2 (Delta variant) | G30X55 | 100 μg；500 μg |
| SARS-CoV-2 Spike protein Receptor Binding Domain (RBD of WT) | G50N28 | 100 μg；500 μg |
| SARS-CoV-2 Spike protein Receptor Binding Domain (RBD of WT) | G9Y25 | 100 μg；500 μg |
| SARS-CoV-2 Spike protein Receptor Binding Domain (RBD of WT) | W81X36 | 100 μg；500 μg |
| SARS-CoV-2 Beta Spike Receptor Binding Domain (RBD) | S78R66 | 100 μg；500 μg |
| SARS-CoV-2 Delta Spike Receptor Binding Domain (RBD) | T21S71 | 100 μg；500 μg |
| SARS-CoV-2 Omicron Spike protein Receptor Binding Domain (RBD) | H53Q62 | 100 μg；500 μg |
| SARS-CoV-2 Omicron BA.2 Spike protein Receptor Binding Domain (RBD) | J38S96 | 100 μg；500 μg |
| SARS-CoV-2 Omicron BA.2.12.1 Spike protein Receptor Binding Domain (RBD) | K53J91 | 100 μg；500 μg |
| SARS-CoV-2 Omicron BA.2.75 Spike protein Receptor Binding Domain (RBD) | Z16Z77 | 100 μg；500 μg |
| SARS-CoV-2 Omicron BA.4/5 Spike protein Receptor Binding Domain (RBD) | B90Y94 | 100 μg；500 μg |
| SARS-CoV-2 Spike protein N-terminal Domain (NTD) | R94E65 | 100 μg；500 μg |
| SARS-CoV-2 Trimeric Spike protein S2 subunit | B85Q65 | 100 μg；500 μg |
| Varicella-Zoster virus (VZV) gE protein | W20T69 | 100 μg；500 μg |
| Venezuelan equine encephalitis virus (VEEV) E1 protein (strain TC-83) | M71T84 | 100 μg；500 μg |
| Venezuelan equine encephalitis virus (VEEV) E3E2 protein (strain TC-83) | G27T62 | 100 μg；500 μg |
| Zika virus E protein Domain III | X38F9 | 100 μg；500 μg |
| Zika virus E protein | P97H90 | 100 μg；500 μg |
| Human CD8 Alpha&Beta (CD8A&CD8B) Heterodimer Protein | W30Y61 | 100 μg；500 μg |
| Human Recombinant PD-L1 Protein (Q47E) | P82C81 | 100 μg；500 μg |
| Human Recombinant Prostate-Specific Antigen | E37Z34 | 100 μg；500 μg |
| Human VEGFR2 Protein (His tag) | J82W46 | 100 μg；500 μg |
| Anti-Cytomegalovirus gB Monoclonal Antibody | D53Y20 | 100 μg; 500 μg |
| Anti-Dengue E Domain III Monoclonal Neutralizing Antibody | K34Q76 | 100 μg; 500 μg |
| Anti-Ebola Broad Neutralizing Antibody | P5N48 | 100 μg; 500 μg |
| Anti-Ebola Glycoprotein Base Monoclonal Neutralizing Antibody (KZ52) | Y90H86 | 100 μg; 500 μg |
| Anti-Ebola SUDV Glycoprotein Base Monoclonal Neutralizing Antibody (16F6) | Z15Q64 | 100 μg; 500 μg |
| Anti-Ebola SUDV Glycoprotein GP1/GP2 interface Monoclonal Neutralizing Antibody | R86C64 | 100 μg; 500 μg |
| Anti-HCV E2 Neutralizing Monoclonal Antibody | X81H49 | 100 μg; 500 μg |
| Anti-Herpes Simplex Virus gD Antibody | Y48B93 | 100 μg; 500 μg |
| Recombinant Human Anti-hMPV Fusion IgM Antibody | R7V27 | 20 μg; 100 μg |
| Recombinant Human Anti-hMPV Fusion IgA Antibody | A89X2 | 20 μg; 100 μg |
| Anti-His Tag Bovine Monoclonal Antibody | B49N2 | 10 μg；50 μg |
| Anti-His Tag Human Antibody | J96C86 | 100 μg; 500 μg |
| Anti-His Tag Mouse Antibody | R44J3 | 100 μg; 500 μg |
| Anti-His Tag Porcine Monoclonal Antibody | K8Q19 | 10 μg；50 μg |
| Anti-His Tag Sheep Monoclonal Antibody | K49T46 | 10 μg；50 μg |
| Anti-HIV-1 Human Monoclonal Antibody | N78A72 | 100 μg; 500 μg |
| Anti-Human Carcinoembryonic Antigen (CEA) Monoclonal Antibody | Y62E54 | 100 μg; 500 μg |
| Anti-Human CD33 Monoclonal Antibody | F28L37 | 100 μg; 500 μg |
| Anti-Human CD8 Alpha Monoclonal Antibody | U18G96 | 100 μg; 500 μg |
| Anti-Human PD1 (CD279) Monoclonal Antibody | Z49H39 | 100 μg; 500 μg |
| Anti-Human PD-L1 Monoclonal Antibody | F16S89 | 100 μg; 500 μg |
| Anti-Human VEGFR2 Monoclonal Antibody | P11C36 | 100 μg; 500 μg |
| Anti-PSA Recombinant Human Monoclonal Antibody | W24D36 | 100 μg; 500 μg |
| Anti-Influenza HA Neutralizing Monoclonal Antibody (H5-specific) | E3V21 | 100 μg; 500 μg |
| Anti-Lassa Virus GP Monoclonal Neutralizing Antibody | M17T52 | 100 μg; 500 μg |
| Anti-Marburg Virus Glycoprotein Monoclonal Neutralizing Antibody | J13W42 | 100 μg; 500 μg |
| Anti-MERS S NTD Monoclonal Neutralizing Antibody | B73K78 | 100 μg; 500 μg |
| Anti-Monkeypox A35R Monoclonal Antibody | Q94A10 | 100 μg; 500 μg |
| Anti-Mouse CD8 Alpha Monoclonal Antibody | C94Y89 | 100 μg; 500 μg |
| Anti-Mouse CD8 Beta Monoclonal Antibody | E8V32 | 100 μg; 500 μg |
| Anti-Myc Tag Human Antibody | M52T82 | 100 μg; 500 μg |
| Anti-Myc Tag Mouse Antibody | G36D52 | 100 μg; 500 μg |
| Anti-Nipah Virus Glycoprotein Human Monoclonal Antibody | M72A69 | 100 μg; 500 μg |
| Anti-Rabies Virus G Antibody (Domain III-specific) | N98S38 | 100 μg; 500 μg |
| Anti-Rabies Virus G Antibody (Trimer-specific) | V70Y47 | 100 μg; 500 μg |
| Anti-RSV Fusion Human Monoclonal Antibody | M72M26 | 100 μg; 500 μg |
| Anti-RSV and HMPV Cross-reactive F Monoclonal Antibody | C21R68 | 100 μg; 500 μg |
| Recombinant Human Anti-RSV and HMPV Cross-reactive F IgM Antibody | L46X29 | 20 μg; 100 μg |
| Recombinant Human Anti-RSV and HMPV Cross-reactive F IgA Antibody | M96T49 | 20 μg; 100 μg |
| Anti-SARS (2003 strain) S RBD Monoclonal Neutralizing Antibody | X42K12 | 100 μg; 500 μg |
| Anti-SARS Spike Recombinant Human Antibody (CR3022) | Y59H10 | 100 μg; 500 μg |
| Anti-SARS and SARS-CoV-2 S RBD Monoclonal Neutralizing Antibody | Z84N67 | 100 μg; 500 μg |
| Recombinant Human Anti-SARS or SARS-CoV-2 S RBD IgM Antibody | P80H48 | 20 μg; 100 μg |
| Recombinant Human Anti-SARS or SARS-CoV-2 S RBD IgA Antibody | Q74F36 | 20 μg; 100 μg |
| Anti-SARS-CoV-2 S NTD Monoclonal Neutralizing Antibody | H28V55 | 100 μg; 500 μg |
| Anti-SARS-CoV-2 S RBD Monoclonal Neutralizing Antibody | F5L83 | 100 μg; 500 μg |
| Anti-SARS-CoV-2 S S2 Human Monoclonal Antibody (non - neutralizing) | V87W71 | 100 μg; 500 μg |
| Anti-SARS-CoV-2 S S2 Monoclonal Neutralizing Antibody | P27D99 | 100 μg; 500 μg |
| Anti-SARS-CoV-2 Nucleocapsid Human Monoclonal Antibody | W89S59 | 100 μg; 500 μg |
| Anti-Varicella-Zoster virus (VZV) Monoclonal IgG Antibody (gE-specific) | J65C52 | 100 μg; 500 μg |
| Recombinant Human Anti-VZV gE IgA Antibody | N42Z57 | 20 μg; 100 μg |
| Recombinant Human Anti-VZV gE IgM Antibody | Z43R73 | 20 μg; 100 μg |
| Anti-Venezuelan Equine Encephalitis Virus Envelope Glycoprotein Antibody | L80U76 | 100 μg; 500 μg |
| Anti-Zika Virus Envelope Neutralizing Antibody | Y95T68 | 100 μg; 500 μg |
| Human Polyclonal IgG, Affinity Purified | P61W44 | 1mg; 5mg |
| Human AAV Capsid Antibody IgG Titer Serologic Assay Kit (Serotype 1, 2, 5, 6, 7, 8, 9, DJ) | C39J57 | 96-well |
| Human Anti-Cytomegalovirus gB Protein Antibody IgG Titer Serologic Assay Kit | W19V42 | 96-well |
| Human Anti-Dengue Antibody IgG Titer Serologic Assay Kit (E) | P76A64 | 96-well |
| Human Anti-Ebola Antibody IgG Titer Serologic Assay Kit (Trimeric GP) | P78G86 | 96-well |
| Human Anti-HIV-1 Antibody IgG Titer Serologic Assay Kit (Trimeric GP140) | R29T18 | 96-well |
| Human Anti-HMPV Fusion Glycoprotein Antibody IgG Titer Serologic Assay Kit (subtype A1& B1) | R28W56 | 96-well |
| Human Anti-HMPV Fusion Glycoprotein Antibody IgM Titer Serologic Assay Kit (subtype A1& B1) | M5Q48 | 96-well |
| Human Anti-HMPV Fusion Glycoprotein Antibody IgA Titer Serologic Assay Kit (subtype A1& B1) | Q82X76 | 96-well |
| Human Anti-HPV L1 Protein Antibody IgG Titer Serologic Assay Kit (subtypes 16&18) | C96J69 | 96-well |
| Human Anti-HSV gD Protein Antibody IgG Titer Serologic Assay Kit (subtypes 1&2) | F55M14 | 96-well |
| Human Anti-Influenza A Hemagglutinin (HA) Antibody IgG Titer Serologic Assay Kit (H5) | Z48C46 | 96-well |
| Human Anti-Influenza Nucleoprotein Antibody IgG Titer Serologic Assay Kit (subtype A & B) | B20S85 | 96-well |
| Human Kallikrein 3/PSA Quantitative ELISA (Ultra-sensitive) | S64N86 | 96-well |
| Human Anti-Marburg Antibody IgG Titer Serologic Assay Kit (Trimeric GP) | S63U27 | 96-well |
| Human Anti-MERS Antibody IgG Titer Serologic Assay Kit (Trimeric spike) | C7C45 | 96-well |
| Human Anti-Monkeypox Antibody IgG Titer Serologic Assay Kit (2022 strain) | A5G21 | 96-well |
| Human Anti-Nipah Virus Glycoprotein Antibody IgG Titer Serologic Assay Kit | N63F95 | 96-well |
| Human Anti-RSV Fusion Glycoprotein Antibody IgG Titer Serologic Assay Kit (subtype A & B) | V84L44 | 96-well |
| Human Anti-RSV Fusion Glycoprotein Antibody IgM Titer Serologic Assay Kit (subtype A & B) | K8K28 | 96-well |
| Human Anti-RSV Fusion Glycoprotein Antibody IgA Titer Serologic Assay Kit (subtype A & B) | C43B15 | 96-well |
| Human Anti-SARS Antibody IgG Titer Serologic Assay Kit (Spike RBD) | B30V87 | 96-well |
| Human Anti-SARS Antibody IgM Titer Serologic Assay Kit (Spike RBD) | P40G52 | 96-well |
| Human Anti-SARS Antibody IgA Titer Serologic Assay Kit (Spike RBD) | H27L32 | 96-well |
| Human Anti-SARS Antibody IgG Titer Serologic Assay Kit (Trimeric spike) | G20S55 | 96-well |
| Human Anti-SARS Antibody IgM Titer Serologic Assay Kit (Trimeric spike) | N87E81 | 96-well |
| Human Anti-SARS Antibody IgA Titer Serologic Assay Kit (Trimeric spike) | F5L75 | 96-well |
| Human Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (Trimeric spike of WT or Variants) | G51F57 | 96-well |
| Human Anti-SARS-CoV-2 Spike (Trimer) IgM Titer Serologic Assay Kit | D68J64 | 96-well |
| Human Anti-SARS-CoV-2 Spike (Trimer) IgA Titer Serologic Assay Kit | D43L97 | 96-well |
| Human Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (spike RBD of WT or Variants) | T11K48 | 96-well |
| Human Anti-SARS-CoV-2 Spike RBD IgM Titer Serologic Assay Kit | W95V9 | 96-well |
| Human Anti-SARS-CoV-2 Spike RBD IgA Titer Serologic Assay Kit | D71N96 | 96-well |
| Human Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (nucleocapsid, N) | N79L14 | 96-well |
| Human Anti-Varicella-Zoster virus (VZV) gE Protein Antibody IgG Titer Serologic Assay Kit | B93H1 | 96-well |
| Human Anti-Varicella-Zoster virus (VZV) gE Protein Antibody IgA Titer Serologic Assay Kit | Z12H55 | 96-well |
| Human Anti-Varicella-Zoster virus (VZV) gE Protein Antibody IgM Titer Serologic Assay Kit | W53Q82 | 96-well |
| Human Anti-Venezuelan Equine Encephalitis Virus (VEEV) Envelope Antibody IgG Titer Serologic Assay Kit | T29V19 | 96-well |
| Human Anti-Zika Antibody IgG Titer Serologic Assay Kit (E of Zika) | G69R89 | 96-well |
| Mouse Anti-Cytomegalovirus gB Protein Antibody IgG Titer Serologic Assay Kit | X66D33 | 96-well |
| Mouse Anti-Dengue Antibody IgG Titer Serologic Assay Kit (E) | J9E30 | 96-well |
| Mouse Anti-Ebola Antibody IgG Titer Serologic Assay Kit (Trimeric GP) | P47J20 | 96-well |
| Mouse Anti-HIV-1 Antibody IgG Titer Serologic Assay Kit (Trimeric GP140) | H52F37 | 96-well |
| Mouse Anti-HPV L1 Protein Antibody IgG Titer Serologic Assay Kit (subtypes 16&18) | C82N87 | 96-well |
| Mouse Anti-HSV gD Protein Antibody IgG Titer Serologic Assay Kit (subtypes 1&2) | Y45N73 | 96-well |
| Mouse Anti-Influenza A Hemagglutinin (HA) Antibody IgG Titer Serologic Assay Kit (H5) | L41Z11 | 96-well |
| Mouse Anti-Influenza Nucleoprotein Antibody IgG Titer Serologic Assay Kit (subtype A & B) | Y70S24 | 96-well |
| Mouse Anti-Marburg Antibody IgG Titer Serologic Assay Kit (Trimeric GP) | Q80S4 | 96-well |
| Mouse Anti-MERS Antibody IgG Titer Serologic Assay Kit (Trimeric spike) | K37A66 | 96-well |
| Mouse Anti-Monkeypox Antibody IgG Titer Serologic Assay Kit (2022 strain) | W10A2 | 96-well |
| Mouse Anti-Nipah Virus Glycoprotein Antibody IgG Titer Serologic Assay Kit | E60G23 | 96-well |
| Mouse Anti-RSV Fusion Glycoprotein Antibody IgG Titer Serologic Assay Kit (subtype A & B) | Q72Y17 | 96-well |
| Mouse Anti-SARS Antibody IgG Titer Serologic Assay Kit (spike RBD) | N55V43 | 96-well |
| Mouse Anti-SARS Antibody IgG Titer Serologic Assay Kit (Trimeric spike) | Z48E90 | 96-well |
| Mouse Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (Trimeric spike of WT or Variants) | Y63W20 | 96-well |
| Mouse Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (spike RBD of WT or Variants) | L69J91 | 96-well |
| Mouse Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (nucleocapsid, N) | X28V90 | 96-well |
| Mouse Anti-Zika Antibody IgG Titer Serologic Assay Kit (E of Zika) | Y26T92 | 96-well |
| Bovine and Sheep Brucella Antibody IgG Titer Serologic Assay Kit | N5M98 | 96-well |
| Sheep Peste Des Petits Ruminants Virus Antibody IgG Titer Serologic Assay Kit | B25G25 | 96-well |
| Swine Anti-African Swine Fever Virus Antibody IgG Titer Serologic Assay Kit | J8G58 | 96-well |
| Swine Anti-Pseudorabies Virus Antibody IgG Titer Serologic Assay Kit | B29G36 | 96-well |
| Swine Anti-Porcine Parvovirus Antibody IgG Titer Serologic Assay Kit | K10H97 | 96-well |
| Swine Anti-RSV Fusion Glycoprotein Antibody IgG Titer Serologic Assay Kit (subtype A & B) | N36S16 | 96-well |
| Seamless Assembly Master Mix (2X) | Q72R56 | 50μl; 250μl; 1ml |
| One-Minute Competent Cells (Stbl2 similar) | L86Z19 | 8 x 50 μl; 96 x 50 ul |
| One-Minute Competent Cells (DH5 Alpha) | L2A1 | 8 x 50 μl; 96 x 50 ul |
